Characteristics of tetrocarcin-A compared with other anti-piroplasmotic drugs.
Namikawa
K
K
Sakuma
Y
Y
Sunaga
F
F
Kanno
Y
Y
D000617:Aminoglycosides; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity*; D001404:Babesiosis / Q000188:drug therapy*; D004133:Diminazene / Q000627:therapeutic use / Q000633:toxicity; D005260:Female; D007928:Lethal Dose 50; D051379:Mice; D011806:Quinolinium Compounds / Q000627:therapeutic use / Q000633:toxicity; D014508:Urea / Q000031:analogs & derivatives / Q000627:therapeutic use / Q000633:toxicity
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000981:Antiprotozoal Agents; D011806:Quinolinium Compounds; C025518:tetrocarcin A; D014508:Urea; C009154:quinuronium sulfate; D004133:Diminazene